| Today's Open | $13.65 |
|---|---|
| Previous Close | $13.66 |
| Daily Range | $13.49 - $13.76 |
| 52-Week Range | $9.37 - $14.80 |
| Market Cap | $6.9B |
| P/E Ratio | -21.68 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 13,126,631 |
| Average Daily Volume | 13,933,451 |
| Current FY EPS | $0.19 |
Sector
Healthcare
Industry
Drugs
Elan (ELN) Description
The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Website: http://www.elan.com/
News & Commentary
Elan Shareholder's Vote Nixes Royalty Pharma Deal
The approval of a shareholder resolution ends a takeover bid for the pharma, pending a review.Theravance Will Split Into 2 Companies After Losing Elan Bid
Elan seeks bids from those wanting to buy it, including Royalty Pharma.ELN's Top Competitors
(-1.24%)
(0.85%)
(0.89%)
(1.28%)